Literature DB >> 26242959

What Will It Take to Address the Global Threat of Antibiotic Resistance?

Steven J Hoffman1, Kevin Outterson2.   

Abstract

In March 2015, the Dag Hammarskjöld Foundation convened a workshop in Uppsala, Sweden to address questions about antibiotic resistance, in partnership with the Global Strategy Lab, the Journal of Law, Medicine & Ethics (JLME), the Norwegian Institute of Public Health, and ReAct - Action on Antibiotic Resistance. Eleven concise articles were commissioned to explore whether ABR depended on global collective action, and if so, what tools could help states and non-state actors to achieve it. This article introduces that collection, which is found in an online-only symposium at aslme.org.
© 2015 American Society of Law, Medicine & Ethics, Inc.

Mesh:

Year:  2015        PMID: 26242959     DOI: 10.1111/jlme.12253

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  12 in total

1.  International law's effects on health and its social determinants: protocol for a systematic review, meta-analysis, and meta-regression analysis.

Authors:  Steven J Hoffman; Matthew Hughsam; Harkanwal Randhawa; Lathika Sritharan; Gordon Guyatt; John N Lavis; John-Arne Røttingen
Journal:  Syst Rev       Date:  2016-04-16

2.  Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.

Authors:  Susan Rogers Van Katwyk; Jeremy M Grimshaw; Miriam Nkangu; Ranjana Nagi; Marc Mendelson; Monica Taljaard; Steven J Hoffman
Journal:  PLoS Med       Date:  2019-06-11       Impact factor: 11.069

Review 3.  Strengthening the science of addressing antimicrobial resistance: a framework for planning, conducting and disseminating antimicrobial resistance intervention research.

Authors:  S Rogers Van Katwyk; S J Hoffman; M Mendelson; M Taljaard; J M Grimshaw
Journal:  Health Res Policy Syst       Date:  2020-06-08

4.  Discovery of Brominated Alboflavusins With Anti-MRSA Activities.

Authors:  Chao Li; Wuyundalai Bao; Haoyue Zhang; Zhitang Lyu; Yihua Chen; Zhengyan Guo
Journal:  Front Microbiol       Date:  2021-02-16       Impact factor: 5.640

5.  Social, cultural and economic aspects of antimicrobial resistance.

Authors:  Timo Minssen; Kevin Outterson; Susan Rogers Van Katwyk; Pedro Henrique D Batista; Clare I R Chandler; Francesco Ciabuschi; Stephan Harbarth; Aaron S Kesselheim; Ramanan Laxminarayan; Kathleen Liddell; Michael T Osterholm; Lance Price; Steven J Hoffman
Journal:  Bull World Health Organ       Date:  2020-12-01       Impact factor: 9.408

6.  Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

Authors:  Kevin Outterson; Unni Gopinathan; Charles Clift; Anthony D So; Chantal M Morel; John-Arne Røttingen
Journal:  PLoS Med       Date:  2016-06-14       Impact factor: 11.069

7.  Developing an approach to assessing the political feasibility of global collective action and an international agreement on antimicrobial resistance.

Authors:  Susan Rogers Van Katwyk; Marie Évelyne Danik; Ioana Pantis; Rachel Smith; John-Arne Røttingen; Steven J Hoffman
Journal:  Glob Health Res Policy       Date:  2016-12-13

8.  Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship-A Tale of Two Countries.

Authors:  Lucille Malan; Quinten Labuschagne; Erich Brechtelsbauer; Debra A Goff; Natalie Schellack
Journal:  Front Public Health       Date:  2018-11-14

9.  Berberine Damages the Cell Surface of Methicillin-Resistant Staphylococcus aureus.

Authors:  Xiujuan Zhang; Xiaoying Sun; Jiaxin Wu; Yue Wu; Yali Wang; Xiaoqing Hu; Xiaoyuan Wang
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

10.  Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review.

Authors:  S Rogers Van Katwyk; J M Grimshaw; M Nkangu; M Mendelson; M Taljaard; S J Hoffman
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.